The role of integrins in cancer and the development of anti-integrin therapeutic agents for cancer therapy
- PMID: 19787098
- PMCID: PMC2746574
The role of integrins in cancer and the development of anti-integrin therapeutic agents for cancer therapy
Abstract
Integrins have been reported to mediate cell survival, proliferation, differentiation, and migration programs. For this reason, the past few years have seen an increased interest in the implications of integrin receptors in cancer biology and tumor cell aggression. This review considers the potential role of integrins in cancer and also addresses why integrins are present attractive targets for drug design. It discusses of the several properties of the integrin-based chemotherapeutic agents currently under consideration clinically and provides an insight into cancer drug development using integrin as a target.
Keywords: cancer; disintegrin; integrin; ligand.
Figures
References
- 
    - Ahmed N, Riley C, Rice GE, et al. Alpha(v)beta(6) integrin-A marker for the malignant potential of epithelial ovarian cancer. J. Histochem. Cytochem. 2002;50:1371–80. - PubMed
 
- 
    - Ahmed N, Riley C, Rice G, et al. Role of integrin receptors for fibronectin, collagen and laminin in the regulation of ovarian carcinoma functions in response to a matrix microenvironment. Clin. Exp. Metastasis. 2005;22:391–402. - PubMed
 
- 
    - Agrez M, Gu X, Turton J, et al. The alpha v beta 6 integrin induces gelatinase B. secretion in colon cancer cells. Int. J. Cancer. 1999;81:90–7. - PubMed
 
- 
    - Alghisi GC, Ruegg C. Vascular integrins in tumor angiogenesis: mediators and therapeutic targets. Endothelium. 2006;13:113–35. - PubMed
 
LinkOut - more resources
- Full Text Sources
- Other Literature Sources
- Miscellaneous
 
        